Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 9,412

Document Document Title
WO/2019/138422A1
The present invention provides a novel and improved process for the preparation of Crisaborole of Formula (I) and its pharmaceutically acceptable salts. The present invention also provides novel intermediates and process for the preparat...  
WO/2019/134556A1
A small-molecule compound capable of inhibiting phosphodiesterase 4 (PDE-4 enzyme), a preparation method thereof, and a pharmaceutical composition comprising the compound. The compound is a boron-containing small molecule having a quinol...  
WO/2018/086730A9
Metal complexes including cyclopentadienyl ligands and methods of using such metal complexes to prepare metal-containing films are provided.  
WO/2019/131691A1
Provided is a fused-ring compound which exhibits an excellent charge-transporting ability over a long period and is useful in producing organic electroluminescent elements. The fused-ring compound has a specific structure and is represen...  
WO/2019/128633A1
The present invention relates to a boron-containing heterocyclic compound, a high polymer, a mixture, and a composition and the use thereof, wherein the boron-containing heterocyclic compound has a structure as shown in general formula (...  
WO/2019/132040A1
Provided is a compound represented by equation (1) below (where, at least one among R1-R8 is a group represented by equation (2) below).  
WO/2019/132506A1
The present specification provides a compound of chemical formula 1 and an organic light emitting element comprising the same.  
WO/2019/133699A1
The present disclosure relates to a capped dual-headed organoaluminum composition having the formula (I) and processes to prepare the same. In at least one aspect, the capped dual-headed organoaluminum compositions can be used in olefin ...  
WO/2019/131898A1
The present invention realizes a technology that makes it possible to efficiently and inexpensively synthesize an organic magnesium compound simply, in a small number of steps, and without requiring cumbersome chemistry procedures. The p...  
WO/2019/133705A1
The present disclosure relates to dual-headed organoaluminum compositions having the formula (I) and processes to prepare the same. In at least one aspect, the compositions having the formula (I) may be used during olefin polymerization.  
WO/2019/131079A1
By using this novel compound which is represented by general formula (1) and which includes boron as a spiro atom, and a macromolecular compound of said compound, the present invention provides a superior organic EL element. (1): Rings A...  
WO/2019/132479A1
The present specification relates to a nitrogen-containing cyclic compound, and a color conversion film, a backlight unit and a display device including the same.  
WO/2019/132028A1
This compound is represented by formula (1) (one or more of pairs among R12 and R13, R13 and R14, R14 and R15, R16 and R17, R17 and R18, and R18 and R19 each independently form a ring represented by formula (2A) or a ring represented by ...  
WO/2019/130229A1
The present invention relates to a process for preparing rucaparib or pharmaceutically acceptable salts thereof. It also provides novel intermediates that may be converted into rucaparib or pharmaceutically acceptable salts thereof.  
WO/2019/120637A1
The present invention relates to a process for the preparation of crisaborole of formula (I): by preparing intermediates of formulas (II) and (III).  
WO/2019/093806A3
The present specification relates to a compound, and a color conversion film a backlight unit, and a display device each comprising the compound.  
WO/2019/126730A1
The invention relates to inhibitors of PI5P4K inhibitors useful in the treatment of cancers, neurodegenerative diseases, inflammatory disorders, and metabolic diseases, having the Formula (I); where A1, A2, G, R1, R2, R3, R4, and W are d...  
WO/2019/120497A1
The invention relates to a hydrosilylable mixture M containing (A) a compound having at least one hydrogen atom directly bound to Si, (B) a compound that contains at least one carbon–carbon multiple bond, and (C) a compound that contai...  
WO/2019/120743A1
The present invention is in the field of processes for preparing inorganic metal-containing films. The process for preparing inorganic metal-containing films comprising bringing a solid substrate in contact with a compound of general for...  
WO/2019/120296A1
The present invention relates to heterocyclic compounds as arginase inhibitors, in particular to a compound represented by Formula (I), or a pharmaceutically acceptable salt, stereoisomer or tautomer, or prodrug thereof and a pharmaceuti...  
WO/2019/115646A1
The invention relates to the use of a metal complex, which has at least one ligand of the formula R1-N3-R2, wherein R1 and R2 are hydrocarbon moieties, for depositing the metal or a compound of the metal from the gas phase. The invention...  
WO/2019/114326A1
Provided are a taurine-substituted bodipy fluorescent compound and a preparation method therefor. The method comprises: reacting 8‐(4-position-substituted-phenyl)‐3,5‐diiodo‐1,2,6,7 ‐tetrasubstituted bodipy and 1,2-disubstitute...  
WO/2019/118884A1
Various compositions are disclosed for the treatment of viral infections. The compositions comprise antibody constructs directed to the liver, attached to myeloid cell agonists, specifically TLR7 and TLR8 agonists, via a linker. Addition...  
WO/2019/113693A1
Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are re...  
WO/2019/115616A1
The present invention relates to Novel 1,7-dicarba-closo- dodecaborane(12) (meta-carbaborane)-derived carboxylic acids suitable for peptide modification for application in boron neutron capture therapy (BNCT).  
WO/2019/115611A1
The present invention covers peptidic BB2 receptor agonist –saccharide functionalised carbaborane conjugate compounds of general formula (I), in which L-Gln, L-Trp, L-Ala, L-Val, β-Ala, L-His, L-Nle, Z, n, X, m, and CbDare as describe...  
WO/2019/115617A1
The present invention relates to Novel 1,7-dicarba-closo-dodecaborane (meta-carbaborane)-derived carboxylic acids and amines according to Formula (I) suitable for peptide modification for application in boron neutron capture therapy (BNC...  
WO/2019/114764A1
The present invention relates to an organometallic complex as shown in general formula (I), and to a polymer, mixture and composition comprising same, and to use thereof in an electronic device, in particular the use in an organic lumino...  
WO/2019/115377A1
Process for the removal of gallium compounds from dimethyl aluminium chloride (DMAC)-containing compositions, comprising the steps of: (i) adding methyl aluminium sesquichloride (MASC) to said DMAC-containing composition, thereby forming...  
WO/2019/115609A1
The present invention covers peptidic human Y1 receptor agonist - saccharide functionalised carbaborane conjugate compounds of general formula (I): X5PSX1PX6FPGX7X8X9PX10X11X12X13X2X14YYX3X15X16X17X4YINLITRPR Y-NH2, in which F, G, I, L, ...  
WO/2019/111796A1
A purpose of the present invention is to provide a photosensitive resin composition which retains satisfactory image resolution and gives cured objects reduced in wet-heat dissolution or contamination and having satisfactory wet-heat adh...  
WO/2019/109802A1
The present invention provides a compound of formula (A), a crystal form thereof, and a preparation of the same. The present invention also provides a pharmaceutical composition comprising the compound of formula (A) and a method of trea...  
WO/2019/112369A1
The present specification relates to a nitrogen-containing compound, a color conversion film comprising the same, and a backlight unit and a display device each comprising same.  
WO/2019/108969A1
Disclosed are to metallocyclopropene complexes, methods of making same, methods for ring expansion metathesis polymerization, and polymers prepared by the methods for ring expansion metathesis polymerization.  
WO/2019/108982A1
A benzoxaborole formulation composition including a benzoxaborole, a non-ionic surfactant, or a non-ionic and ionic surfactant mixture, and a carrier is described herein. At least one of the non-ionic surfactant, the non-ionic and ionic ...  
WO/2018/067762A3
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing...  
WO/2019/101560A1
The present invention relates to the use of the compounds of formula (I), wherein the variables are defined according to the description, for controlling unwanted vegetation. Further the invention relates to novel compounds of the formul...  
WO/2019/103155A1
Provided is a highly photostable europium complex. The europium complex is represented by formula (A): [in the formula, RA and RB are each independently a C3-10 cycloalkyl group and RC is a C3-10 cycloalkyl group or a phenyl group repres...  
WO/2019/098286A1
Disclosed is a rare earth compound which contains two trivalent rare earth ions and two phosphine oxide ligands represented by formula (I). The two rare earth ions are connected to one another by the two phosphine oxide ligands which are...  
WO/2019/099576A1
Provided herein are compounds, such as a compound of Formula (I), or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment...  
WO/2019/099582A1
Provided herein are compounds, such as a compound of Formula (I), or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be useful for the treatment...  
WO/2019/096113A1
A deuterium-substitute 5-(4-cyanophenoy)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole compound represented by formula (I) or a pharmaceutically acceptable salt, prodrug, hydrate or solvate compound, polymorph, stereoisomer, or isotopic variat...  
WO/2019/096762A1
The invention relates to methods for forming CC bonds with use of organolithium compounds under continuous flow conditions in a micro or meso reactor system, in which an organic substrate is reacted with an alkyl lithium compound in the ...  
WO/2019/093806A2
The present specification relates to a compound, and a color conversion film a backlight unit, and a display device each comprising the compound.  
WO/2019/092125A1
This invention relates to glucose-sensitive albumin-binding diboron conjugates. More particularly the invention provides novel diboron compounds, and in particular diboronate or diboroxole compounds, useful as intermediate compounds for ...  
WO/2019/093805A1
The present specification relates to: a nitrogenous compound; and a color changing film, a backlight unit and a display device, which comprise the nitrogenous compound.  
WO/2019/091534A1
There is provided two angiogenesis clinical PET tracers, namely 68Ga-NODAGA- E[c(RGDyK)]2 and 64Cu-NODAGA-E[c(RGDyK)]2 for imaging of neo-angiogenesis in humans.  
WO/2019/088799A1
The present specification provides a compound represented by chemical formula 1 and an organic light-emitting device comprising the same.  
WO/2019/086906A1
Modified solid polymethylaluminoxanes are described for use as support materials for olefin polymerisation catalysts. The modified solid polymethylaluminoxanes have higher specific surface areas than their unmodified analogues. Also desc...  
WO/2019/086336A1
Method for storing and/or transporting GaCl3 involving the step of adding an aluminium compounds of the formula R3 -xAlClx, wherein R is a linear or branched alkyl group with 1-8 carbon atoms and x is 0 or 1, to said GaCl3 in an Al/Ga mo...  

Matches 1 - 50 out of 9,412